KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Cash from Operations: 2010-2024

Historic Cash from Operations for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $1.2 million.

  • TherapeuticsMD's Cash from Operations rose 1507.04% to $999,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 155.06%. This contributed to the annual value of $1.2 million for FY2024, which is 105.07% up from last year.
  • As of FY2024, TherapeuticsMD's Cash from Operations stood at $1.2 million, which was up 105.07% from -$23.1 million recorded in FY2023.
  • Over the past 5 years, TherapeuticsMD's Cash from Operations peaked at $9.4 million during FY2022, and registered a low of -$159.5 million during FY2020.
  • For the 3-year period, TherapeuticsMD's Cash from Operations averaged around -$4.2 million, with its median value being $1.2 million (2024).
  • Its Cash from Operations has fluctuated over the past 5 years, first skyrocketed by 116.98% in 2022, then plummeted by 346.62% in 2023.
  • Over the past 5 years, TherapeuticsMD's Cash from Operations (Yearly) stood at -$159.5 million in 2020, then spiked by 65.43% to -$55.1 million in 2021, then soared by 116.98% to $9.4 million in 2022, then crashed by 346.62% to -$23.1 million in 2023, then surged by 105.07% to $1.2 million in 2024.